Attitudes about involvement in hypothetical clinical trial protocols in Mexican and Mexican-American at risk for autosomal dominant Alzheimer’s disease

BACKGROUND: The enrollment into clinical trials of persons at risk for autosomal dominant Alzheimer’s disease (ADAD) in whom the onset of disease can be accurately predicted facilitates the interpretation of outcomes (e.g., biomarkers, treatment efficacy). Attitudes toward involvement in such studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuno-Reyes, Angélica, Matute, Esmeralda, Ernstrom, Karin, Withers, Mellissa, Rodriguez-Agudelo, Yaneth, Raman, Rema, Ringman, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664662/
https://www.ncbi.nlm.nih.gov/pubmed/36380395
http://dx.doi.org/10.1186/s13195-022-01114-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664662/
https://www.ncbi.nlm.nih.gov/pubmed/36380395
http://dx.doi.org/10.1186/s13195-022-01114-4

Ejemplares similares